Advertisement

Topics

Advanced BioScience Laboratories, Inc. (ABL) Company Profile

00:13 EST 11th December 2018 | BioPortfolio

Profectus is a clinical-stage biotechnology company developing novel vaccines to prevent and treat major chronic viral infectious diseases and associated cancers for which standard of care is inadequate or nonexistent, as well as emerging infectious diseases of public health and biodefense importance. Profectus vaccines are based on the company’s proprietary Prime/Boost System of Vaccines (PBS Vax™) discovery engine, which enables quantitative and qualitative tailoring of effective immune responses to specific disease targets. Clinical studies of PBS Vax™ have shown a favorable safety profile and significantly enhanced immune responses. The PBS Vax™ discovery engine is creating a pipeline of differentiated new vaccines that have the potential to be first-in-class or best-in-class products to treat and prevent diseases. Profectus' lead candidates include a therapeutic and prophylactic vaccine for HIV that initiated human clinical studies in 2013 and is currently being used in the clinic as part of the National Institutes of Health's HIV "Cure Agenda,” and a vaccine against the Ebola and Marburg viruses that provided 100% protection of monkeys against lethal challenge with these agents when tested by the U.S. government. For more information, please visit www.profectusbiosciences.com.


News Articles [864 Associated News Articles listed on BioPortfolio]

Aytu BioScience, Inc.: Aytu BioScience Announces 7 Presentations of Clinical Findings for its Proprietary MiOXSYS(R) System at the 34th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE)

- Multi-Center, Global Study Demonstrates that MiOXSYS Provides an Accurate Measure of Seminal Oxidative Stress that can be Standardized Globally Within Clinical Andrology and IVF Laboratories - Pr...

IDEXX Laboratories Inc Q2 Earnings Rise

WASHINGTON (dpa-AFX) - IDEXX Laboratories Inc (IDXX) released earnings for its second quarter that advanced from last year.The company's profit came in at $108.68 million, or $1.23 per share. This...

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment PR Newswire London, August 5 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATIO...

Aytu BioScience, Inc.: Aytu BioScience Announces Pricing of $13.2 Million Underwritten Public Offering

ENGLEWOOD, CO / ACCESSWIRE / October 5, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant ...

Aytu BioScience, Inc.: Aytu BioScience Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

ENGLEWOOD, CO / ACCESSWIRE / October 10, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant...

Twist Bioscience Files for $86.3M IPO

Today, Twist Bioscience filed an S-1 with the U.S. Securities and Exchange Commission (SEC), announcing its intent to undergo an initial public offering. The filing shows that Twist intends to raise $...

Aytu BioScience, Inc.: Aytu BioScience to Present at 11th Annual LD Micro Main Event Investor Conference on December 5, 2018

ENGLEWOOD, CO / ACCESSWIRE / November 27, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significan...

Aytu BioScience, Inc.: Aytu BioScience Reports 55% Sequential Revenue Growth in Q1 FY19; Adds Tuzistra(R) XR to Portfolio

Company Posts Highest Ever Quarterly Revenue ENGLEWOOD, CO / ACCESSWIRE / November 7, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercializa...

Drugs and Medications [626 Associated Drugs and Medications listed on BioPortfolio]

O24 [Revive Bioscience, Inc.]

Bio-corneum hc advanced scar supervision anti-itch [Advanced Bio-Technologies, Inc]

BIO-CORNEUM HC Advanced Scar Supervision Anti-Itch Gel

Maxclarity [Stiefel Laboratories Inc]

Drug Facts

Shiseido advanced hydro-liquid compact (refill) [SHISEIDO CO., LTD.]

Shiseido Advanced Hydro-Liquid Compact Foundation

Abraxane [Abraxis BioScience, LLC]

These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE ABRAXANE® for Injectable Suspension (paclitaxel protei...

PubMed Articles [977 Associated PubMed Articles listed on BioPortfolio]

Laboratory Safety in Parasitology Laboratory.

Working in a laboratory is very difficult and needs special attention. Laboratory workers can be exposed to numerous potential hazards including chemical, biological, physical, and radioactive. That i...

Optimization of laboratory procedures for intrauterine insemination: survey of methods in relation to clinical outcome.

There is a wide practice variation of used methods and outcomes in IUI in fertility laboratories. Standardization of the IUI procedure is important for reducing inconsistency among laboratories in cou...

Challenges in the analysis of novel flame retardants in indoor dust: results of the INTERFLAB 2 interlaboratory evaluation.

The Interlaboratory Study of Novel Flame Retardants (INTERFLAB 2) was conducted by 20 laboratories in 12 countries to test the precision and accuracy of the analysis of 24 "novel" flame retardants (NF...

Proficiency testing for the detection of Middle East respiratory syndrome-coronavirus demonstrates global capacity to detect MERS-CoV.

The first reported case of Middle East respiratory syndrome-coronavirus (MERS-CoV) infection was identified in Saudi Arabia in September 2012, since which time there have been over 2,000 laboratory-co...

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK.

For patients with chronic myeloid leukaemia (CML), treatment guidelines recommend monitoring response to treatment with tyrosine kinase inhibitors (TKIs) by testing the BCR-ABL1 fusion gene transcript...

Clinical Trials [5088 Associated Clinical Trials listed on BioPortfolio]

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

ARTEMIS DIANE T790M Mutation at Hospital Laboratories in Comparison With Central Laboratory

The study primary objective is to assess the concordance of T790M resistance mutation testing from hospital-based laboratories with T790M resistance mutation testing from a central laborat...

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Companies [2051 Associated Companies listed on BioPortfolio]

Advanced BioScience Laboratories, Inc.

Advanced BioScience Laboratories, Inc. (ABL) and Inviragen, Inc.

Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma

Advanced BioScience Laboratories, Inc

Advanced BioScience Laboratories, Inc (ABL) has an established history of delivering quality services that advance HIV and infectious disease research for the public good. ABL is a contract research...

BioScience Laboratories

Since its inception in 1991, BioScience Laboratories has provided clinical and label claims substantiation studies, evaluating product usage skin condition, including assessments of irritation, moistu...

More Information about "Advanced BioScience Laboratories, Inc. (ABL)" on BioPortfolio

We have published hundreds of Advanced BioScience Laboratories, Inc. (ABL) news stories on BioPortfolio along with dozens of Advanced BioScience Laboratories, Inc. (ABL) Clinical Trials and PubMed Articles about Advanced BioScience Laboratories, Inc. (ABL) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced BioScience Laboratories, Inc. (ABL) Companies in our database. You can also find out about relevant Advanced BioScience Laboratories, Inc. (ABL) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record